• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
In Vitro Diagnostic (IVD) Market, Technique & Applications – Forecast To 2017 - Product Image

In Vitro Diagnostic (IVD) Market, Technique & Applications – Forecast To 2017

  • Published: August 2013
  • 418 Pages
  • Markets and Markets

FEATURED COMPANIES

  • Abbott Laboratories, Inc
  • Arkray, Inc
  • Biomerieux
  • Danaher Corporation
  • Diasorin SPA
  • Horiba, Ltd
  • MORE

'In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] – Forecast To 2017'

The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, microbiology and finally, the geographical market expansion within emerging countries.

The most important trend witnessed recently in the in vitro diagnostic industry is that of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market. The global in vitro disgnostics market READ MORE >

1 Introduction
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.5.5 Assumptions

2 Executive Summary

3 Market Overview
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers & Restraint
3.3.1.1 Rising Incidence Of Chronic And Infectious Diseases In Emerging Economies To Drive The Market
3.3.1.2 Rapidly Aging Population
3.3.1.3 Rise In Point-Of-Care (POC) Testing
3.3.1.4 Personalized Medicine To Propel Growth
3.3.1.5 Lack Of Budget To Restrict Growth
3.3.2 Opportunities
3.3.2.1 Extending Reach Of Molecular Diagnostics
3.3.2.2 New Range Of Condition-Specific Markers And Tests With Advances In Genomics And Proteomics
3.3.3 Challenge
3.3.3.1 Stringent Regulatory Framework Acts As A Major Challenge
3.4 Winning Imperatives
3.4.1 Non-Proprietary System With Enhanced Functionalities
3.5 Burning Issues
3.5.1 Laboratory Automation For Increased Efficiency And Accurate Diagnosis
3.6 Market Share Analysis
3.7 Supply Chain Analysis
3.8 Pestel Analysis
3.8.1 Political
3.8.2 Economic
3.8.3 Socio-Cultural
3.8.4 Technological
3.8.5 Environmental
3.8.6 Legal

4 Global In Vitro Diagnostic Market, By Technique
4.1 Introduction
4.1.1 Clinical Chemistry
4.1.2 Immunochemistry/Immunoassay
4.1.3 Hematology
4.1.4 Coagulation
4.1.5 Microbiology
4.1.6 Molecular Diagnostics
4.1.7 Other Clinical Instruments

5 Global In Vitro Diagnostic Market, By Product Type
5.1 Introduction
5.2 Instruments
5.3 Reagents
5.4 Data Management System Software/Hardware
5.5 Services

6 Global In Vitro Diagnostic Market, By Application
6.1 Introduction
6.2 Diabetes
6.3 Infectious Diseases
6.4 Oncology/Cancer
6.5 Cardiology
6.6 Nephrology
6.7 Autoimmune Diseases
6.8 Drug Testing
6.9 HIV/Aids
6.10 Others

7 Global In Vitro Diagnostic Market, By End-User
7.1 Introduction
7.2 Laboratory
7.3 Hospitals
7.4 Academics
7.5 Point-Of-Care Testing
7.6 Patient Self-Testing
7.7 Others

8 Geographic Analysis
8.1 Introduction
8.2 Americas
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.2.4 Chile
8.2.5 Rest Of Americas (ROA)
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 Italy
8.3.4 Spain
8.3.5 U.K.
8.3.6 Rest Of Europe (ROE)
8.4 Japan
8.5 Bric
8.5.1 Brazil
8.5.2 Russia
8.5.3 India
8.5.4 China
8.6 Rest Of The World (ROW)

9 Competitive Landscape
9.1 Introduction
9.2 New Product Launch
9.3 Agreements, Partnerships, Collaborations & Joint Ventures
9.4 Mergers And Acquisitions
9.5 Other Developments

10 Company Profiles (Overview, Financials, Products & Services, Developments & Strategy)*
10.1 Abbott Laboratories, Inc.
10.2 Alere, Inc.
10.3 Arkray, Inc.
10.4 Bayer AG
10.5 Becton, Dickinson And Company
10.6 Biomerieux
10.7 Bio-Rad Laboratories, Inc.
10.8 Danaher Corporation
10.9 Diagnostica Stago Sas
10.10 Diasorin S.P.A.
10.11 Hologic, Inc.
10.12 Horiba, Ltd.
10.13 Johnson & Johnson
10.14 Novartis International Ag
10.15 Qiagen N.V.
10.16 Roche Diagnostics Limited
10.17 Siemens Healthcare
10.18 Sysmex Corporation
10.19 Thermo Fisher Scientific, Inc.
*Details On Financials, Products & Services, Developments & Strategy Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables (178 Tables)

Table 1 Global In-Vitro Diagnostic Instrument & Reagents Market Revenue, By Technique, 2012 ($Million)
Table 2 Clinical Chemistry Market, By Geography, 2010 – 2017 ($Million)
Table 3 The Americas: Clinical Chemistry Market, By Country, 2010 – 2017 ($Million)
Table 4 Europe: Clinical Chemistry Market, By Country, 2010 – 2017 ($Million)
Table 5 BRIC: Clinical Chemistry Market, By Country, 2010 – 2017 ($Million)
Table 6 Global Clinical Chemistry Market, By Instruments & Reagents, 2010 – 2017 ($Million)
Table 7 Immunochemistry Market, By Geography, 2010 – 2017 ($Million)
Table 8 The Americas: Immunochemistry Market, By Country, 2010 – 2017 ($Million)
Table 9 Europe: Immunochemistry Market, By Country, 2010 – 2017 ($Million)
Table 10 BRIC: Immunochemistry Market, By Country, 2010 – 2017 ($Million)
Table 11 Global Immunochemistry Market, By Instruments & Reagents, 2010 – 2017 ($Million)
Table 12 Hematology Market, By Geography, 2010 – 2017 ($Million)
Table 13 The Americas: Hematology Market, By Country, 2010 – 2017 ($Million)
Table 14 Europe: Hematology Market, By Country, 2010 – 2017 ($Million)
Table 15 BRIC: Hematology Market, By Country, 2010 – 2017 ($Million)
Table 16 Global Hematology Market, By Instruments & Reagents, 2010 – 2017 ($Million)
Table 17 Coagulation Market, By Geography, 2010 – 2017 ($Million)
Table 18 The Americas: Coagulation Market, By Country, 2010 – 2017 ($Million)
Table 19 Europe: Coagulation Market, By Country, 2010 – 2017 ($Million)
Table 20 BRIC: Coagulation Market, By Country, 2010 – 2017 ($Million)
Table 21 Global Coagulation Market, By Instruments & Reagents, 2010 – 2017 ($Million)
Table 22 Microbiology Market, By Geography, 2010 – 2017 ($Million)
Table 23 The Americas: Microbiology Market, By Country, 2010 – 2017 ($Million)
Table 24 Europe: Microbiology Market, By Country, 2010 – 2017 ($Million)
Table 25 BRIC: Microbiology Market, By Country, 2010 – 2017 ($Million)
Table 26 Global Microbiology Market, By Instruments & Reagents, 2010 – 2017 ($Million)
Table 27 Molecular Diagnostics Market, By Geography, 2010 – 2017 ($Million)
Table 28 The Americas: Molecular Diagnostics Market, By Country, 2010 – 2017 ($Million)
Table 29 Europe: Molecular Diagnostics Market, By Country, 2010 – 2017 ($Million)
Table 30 BRIC: Molecular Diagnostics Market, By Country, 2010 – 2017 ($Million)
Table 31 Global Molecular Diagnostics Market, By Instruments & Reagents, 2010 – 2017 ($Million)
Table 32 Other In-Vitro Diagnostic Techniques Market, By Geography, 2010 – 2017 ($Million)
Table 33 The Americas: Other IVD Techniques Market, By Country, 2010 – 2017 ($Million)
Table 34 Europe: Other IVD Techniques Market, By Country, 2010 – 2017 ($Million)
Table 35 BRIC: Other IVD Techniques Market, By Country, 2010 – 2017 ($Million)
Table 36 Global In Vitro Diagnostic Market, By Product Type, 2010 – 2017 ($Million)
Table 37 In Vitro Diagnostic Instruments Market, By Geography, 2010 – 2017 ($Million)
Table 38 The Americas: IVD Instruments Market, By Country, 2010 – 2017 ($Million)
Table 39 Europe: IVD Instruments Market, By Country, 2010 – 2017 ($Million)
Table 40 BRIC: IVD Instruments Market, By Country, 2010 – 2017 ($Million)
Table 41 In Vitro Diagnostic Reagents Market, By Geography, 2010 – 2017 ($Million)
Table 42 The Americas: IVD Reagents Market, By Country, 2010 – 2017 ($Million)
Table 43 Europe: IVD Reagents Market, By Country, 2010 – 2017 ($Million)
Table 44 BRIC: IVD Reagents Market, By Country, 2010 – 2017 ($Million)
Table 45 In Vitro Diagnostic Data Management System Software/Hardware Market, By Geography, 2010 – 2017 ($Million)
Table 46 The Americas: IVD Data Management System Software/Hardware Market, By Country, 2010 – 2017 ($Million)
Table 47 Europe: IVD Data Management System Software/Hardware Market, By Country, 2010 – 2017 ($Million)
Table 48 BRIC: IVD Data Management System Software/Hardware Market, By Country, 2010 – 2017 ($Million)
Table 49 In Vitro Diagnostic Services Market, By Geography, 2010 – 2017 ($Million)
Table 50 The Americas: IVD Services Market, By Country, 2010 – 2017 ($Million)
Table 51 Europe: IVD Services Market, By Country, 2010 – 2017 ($Million)
Table 52 BRIC: IVD Services Market, By Country, 2010 – 2017 ($Million)
Table 53 Global In-Vitro Diagnostics Market, By Application, 2010 – 2017 ($Million)
Table 54 Diabetes In Vitro Diagnostic Market, By Geography, 2010 – 2017 ($Million)
Table 55 Americas: Diabetes IVD Market, By Country, 2010 – 2017 ($Million)
Table 56 Europe: Diabetes IVD Market, By Country, 2010 – 2017 ($Million)
Table 57 BRIC: Diabetes IVD Market, By Country, 2010 – 2017 ($Million)
Table 58 Infectious Diseases In Vitro Diagnostics Market, By Geography, 2010 – 2017 ($Million)
Table 59 Americas: Infectious Diseases IVD Market, By Country, 2010 – 2017 ($Million)
Table 60 Europe: Infectious Diseases IVD Market, By Country, 2010 – 2017 ($Million)
Table 61 BRIC: Infectious Diseases IVD Market, By Country, 2010 – 2017 ($Million)
Table 62 Oncology In Vitro Diagnostic Market, By Geography, 2010 – 2017 ($Million)
Table 63 Americas: Oncology IVD Market, By Country, 2010 – 2017 ($Million)
Table 64 Europe: Oncology IVD Market, By Country, 2010 – 2017 ($Million)
Table 65 BRIC: Oncology IVD Market, By Country, 2010 – 2017 ($Million)
Table 66 Cardiology In Vitro Diagnostic Market, By Geography, 2010 – 2017 ($Million)
Table 67 Americas: Cardiology IVD Market, By Country, 2010 – 2017 ($Million)
Table 68 Europe: Cardiology IVD Market, By Country, 2010 – 2017 ($Million)
Table 69 BRIC: Cardiology IVD Market, By Country, 2010 – 2017 ($Million)
Table 70 Nephrology In Vitro Diagnostic Market, By Geography, 2010 – 2017 ($Million)
Table 71 Americas: Nephrology IVD Market, By Country, 2010 – 2017 ($Million)
Table 72 Europe: Nephrology IVD Market, By Country, 2010 – 2017 ($Million)
Table 73 BRIC: Nephrology IVD Market, By Country, 2010 – 2017 ($Million)
Table 74 Autoimmune Diseases In Vitro Diagnostic Market, By Geography, 2010 – 2017 ($Million)
Table 75 America: Autoimmune Diseases IVD Market, By Country, 2010 – 2017 ($Million)
Table 76 Europe: Autoimmune Diseases IVD Market, By Country, 2010 – 2017 ($Million)
Table 77 BRIC: Autoimmune Diseases IVD Market, By Country, 2010 – 2017 ($Million)
Table 78 Drug Testing In Vitro Diagnostic Market, By Geography, 2010 – 2017 ($Million)
Table 79 Americas: Drug Testing IVD Market, By Country, 2010 – 2017 ($Million)
Table 80 Europe: Drug Testing IVD Market, By Country, 2010 – 2017 ($Million)
Table 81 BRIC: Drug Testing IVD Market, By Country, 2010 – 2017 ($Million)
Table 82 HIV/Aids In Vitro Diagnostic Market, By Geography, 2010 – 2017 ($Million)
Table 83 Americas: Hiv/Aids IVD Market, By Country, 2010 – 2017 ($Million)
Table 84 Europe: Hiv/Aids IVD Market, By Country, 2010 – 2017 ($Million)
Table 85 BRIC: Hiv/Aids IVD Market, By Country, 2010 – 2017 ($Million)
Table 86 Other Applications Market, By Geography, 2010 – 2017 ($Million)
Table 87 America: Other Applications Market, By Country, 2010 – 2017 ($Million)
Table 88 Europe: Other Applications Market, By Country, 2010 – 2017 ($Million)
Table 89 BRIC: Other Applications Market, By Country, 2010 – 2017 ($Million)
Table 90 Global In Vitro Diagnostics Market, By End-User, 2010 – 2017 ($Million)
Table 91 In Vitro Diagnostics Market, By Geography, 2010 – 2017 ($Million)
Table 92 Americas: IVD Market, By Country, 2010 – 2017 ($Million)
Table 93 Americas: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 94 Americas: IVD Market, By Application, 2010 – 2017 ($Million)
Table 95 Americas: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 96 U.S.: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 97 U.S.: IVD Market, By Application, 2010 – 2017 ($Million)
Table 98 U.S.: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 99 Canada: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 100 Canada: IVD Market, By Application, 2010 – 2017 ($Million)
Table 101 Canada: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 102 Mexico: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 103 Mexico: IVD Market, By Application, 2010 – 2017 ($Million)
Table 104 Mexico: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 105 Chile: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 106 Chile: IVD Market, By Application, 2010 – 2017 ($Million)
Table 107 Chile: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 108 ROA: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 109 ROA: IVD Market, By Application, 2010 – 2017 ($Million)
Table 110 ROA: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 111 Europe: IVD Market, By Country, 2010 – 2017 ($Million)
Table 112 Europe: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 113 Europe: IVD Market, By Application, 2010 – 2017 ($Million)
Table 114 Europe: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 115 Germany: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 116 Germany: IVD Market, By Application, 2010 – 2017 ($Million)
Table 117 Germany: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 118 France: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 119 France: IVD Market, By Application, 2010 – 2017 ($Million)
Table 120 France: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 121 Italy: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 122 Italy: IVD Market, By Application, 2010 – 2017 ($Million)
Table 123 Italy: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 124 Spain: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 125 Spain: IVD Market, By Application, 2010 – 2017 ($Million)
Table 126 Spain: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 127 U.K.: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 128 U.K.: IVD Market, By Application, 2010 – 2017 ($Million)
Table 129 U.K.: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 130 ROE: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 131 ROE: IVD Market, By Application, 2010 – 2017 ($Million)
Table 132 ROE: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 133 Japan: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 134 Japan: IVD Market, By Application, 2010 – 2017 ($Million)
Table 135 Japan: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 136 BRIC: IVD Market, By Country, 2010 – 2017 ($Million)
Table 137 BRIC: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 138 BRIC: IVD Market, By Application, 2010 – 2017 ($Million)
Table 139 BRIC: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 140 Brazil: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 141 Brazil: IVD Market, By Application, 2010 – 2017 ($Million)
Table 142 Brazil: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 143 Russia: Aging Population (Thousand)
Table 144 Russia: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 145 Russia: IVD Market, By Application, 2010 – 2017 ($Million)
Table 146 Russia: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 147 India: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 148 India: IVD Market, By Application, 2010 – 2017 ($Million)
Table 149 India: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 150 China: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 151 China: IVD Market, By Application, 2010 – 2017 ($Million)
Table 152 China: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 153 ROW: IVD Market, By Technique, 2010 – 2017 ($Million)
Table 154 ROW: IVD Market, By Application, 2010 – 2017 ($Million)
Table 155 ROW: IVD Market, By Product Type, 2010 – 2017 ($Million)
Table 156 New Product Launch, 2011 – 2013
Table 157 Agreements, Partnerships, Collaborations & Joint Ventures, 2011 – 2013
Table 158 Mergers & Acquisitions, 2011 – 2013
Table 159 Othere Developments, 2011 – 2013
Table 160 Abbott Laboratories, Inc.: Major Developments, 2011 – 2013
Table 161 Alere, Inc.: Major Developments, 2011 – 20113
Table 162 Arkray, Inc.: Major Developments, 2011 – 2013
Table 163 Bayer Ag: Major Developments, 2011 – 2013
Table 164 Becton, Dickinson And Company: Major Developments, 2011 – 2013
Table 165 Biomerieux: Major Developments, 2011 – 2012
Table 166 Bio-Rad Laboratories, Inc.: Major Developments, 2011 – 2012
Table 167 Danaher Corporation: Major Developments, 2011 – 2013
Table 168 Diagnostica Stago Sas: Major Developments, 2011 – 2013
Table 169 Diasorin Inc.: Major Developments, 2011 – 2013
Table 170 Hologic, Inc.: Major Developments, 2011 – 2013
Table 171 Horiba, Ltd.: Major Developments, 2011 – 2012
Table 172 Johnson & Johnson: Major Developments, 2011 – 2012
Table 173 Novartis Ag: Major Developments, 2011 – 2012
Table 174 Qaigen N.V.: Major Developments, 2011 – 2013
Table 175 Roche Holdings: Major Developments, 2011 – 2013
Table 176 Siemens Healthcare: Major Developments, 2011 – 2013
Table 177 Sysmex Corporation: Major Developments, 2011 – 2013
Table 178 Thermo Fisher Scientific, Inc.: Major Developments, 2011 – 2013

List Of Figures (50 Figures)

Figure 1 Global In-Vitro Diagnostic Instrument & Reagents Market,By Technique, 2012 ($Million)
Figure 2 Role Of In-Vitro Diagnostics In Healthcare
Figure 3 In Vitro Diagnostics Market Segmentation
Figure 4 In Vitro Diagnostics Market—Drivers & Restraints
Figure 5 Global In Vitro Diagnostics Market Share Analysis, By Key Player, 2012
Figure 6 In Vitrp Diagnostic Market:Supply Chain Analysis
Figure 7 In Vitro Diagnostic Market: Pestel Analysis
Figure 8 Global In Vitro Diagnostics Market Segmentation, By Technique
Figure 9 Global In Vitro Diagnostics Market, By Technique
Figure 10 Global In Vitro Diagnostics Market, By Geography, 2012
Figure 11 Key Growth Strategies, 2011 – 2013
Figure 12 Abbott Laboratories, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Million)
Figure 13 Abbott Laboratories, Inc.: Market Strategy, 2011 – 2013
Figure 14 Alere, Inc.: Total Revenue, By Segment, 2009 - 2011 ($Million)
Figure 15 Alere, Inc.: Professional Diagnostics Revenue, By Segment, 2011 – 2012 ($Million)
Figure 16 Alere, Inc.: Market Strategy, 2011 – 2013
Figure 17 Arkray, Inc.: Market Strategy, 2011 - 2012
Figure 18 Bayer AG: Total Revenue, By Segment, 2010 – 2012 ($Million)
Figure 19 Becton, Dickinson And Company: Total Revenue, By Segment, 2010 – 2012 ($Million)
Figure 20 Bd Diagnostics: Total Revenue, By Segment, 2010 – 2012 ($Million)
Figure 21 Becton, Dickinson And Company: Market Strategy, 2011 – 2013
Figure 22 Biomerieux: Total Revenue, By Segment, 2010 – 2011 ($Million)
Figure 23 Biomerieux: Market Strategy, 2011 – 2012
Figure 24 Bio-Rad Laboratories, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Million)
Figure 25 Bio-Rad Laboratories, Inc.: Market Srategy, 2011 – 2013
Figure 26 Danaher Corporation: Total Revenue, By Segment, 2010 – 2012 ($Million)
Figure 27 Danaher Corporation: Market Strategy, 2011 – 2013
Figure 28 Diagnostica Stago Sas: Market Strategy, 2011 – 2013
Figure 29 Diasorin S.P.A.: Total Revenue, By Technology, 2010 – 2012, ($Million)
Figure 30 Diasorin S.P.A,: Market Strategy, 2011 – 2013
Figure 31 Hologic, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Million)
Figure 32 Hologic, Inc.: Market Srategy, 2011 – 2013
Figure 33 Horiba Ltd.: Total Revenue, By Segments, 2009 – 2011
Figure 34 Horiba, Ltd.: Market Strategy, 2011 - 2013
Figure 35 Johnson & Johnson: Total Revenue, By Segment, 2010 – 2012 ($Milllion)
Figure 36 Johnson & Johnson: Diagnostics Franchise Revenue, 2010 – 2012 ($Million)
Figure 37 Johnson & Johnson: Market Strategy, 2011 – 2013
Figure 38 Novartis AG: Total Revenue, By Segment, 2010 – 2012
Figure 39 Novartis AG: Market Stretegy, 2011 – 2013
Figure 40 Qiagen N.V.: Total Revenue, By Segment, 2010 – 2012 ($Million)
Figure 41 Qiagen N.V.: Market Srategy, 2011 - 2013
Figure 42 ROCHE Holdings: Diagnostics Revenue, By Segment, 2010 – 2012 ($Million)
Figure 43 ROCHE Holdings: Diagnostics Revenue, By Geography, 2010 – 2012 ($Million)
Figure 44 ROCHE Holdings: Market Strategy, 2011 – 2012
Figure 45 Siemens AG: Total Revenue, By Segment, 2010 – 2012 ($Million)
Figure 46 Siemens Healthcare: Market Strategy, 2011 – 2013
Figure 47 Sysmex Corporation: Diagnostics Segment Revenue, 2010 – 2012 ($Million)
Figure 48 Sysmex Corporation: Market Strategy, 2011 – 2013
Figure 49 Thermo Fisher Scientific, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Million)
Figure 50 Thermo Fisher Scientific, Inc.: Market Srategy, 2011 – 2013

The in vitro diagnostic market studied in this report has been segmented by technology, product type, application, end user, and geography. The technology market is further segmented into clinical chemistry, immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, and others, of which immunochemistry accounted for the largest share with 25.8% in 2010. By product type, the IVD market has segments like instruments, reagents, data management software/hardware, and services.

Based on applications, the in vitro diagnostic market is segmented as diabetes, infectious diseases, oncology, cardiology, nephrology, auto-immune diseases, AIDS, drug testing, and others. Laboratory testing, hospital testing, academic (AMCs and university) testing, point-of-care testing, patient self-testing, and others comprise the end-user segment of the IVD market.

The global in vitro diagnostic market was valued at $49.2 billion in 2012 and is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The IVD market is primarily driven by rising incidences of chronic and infectious diseases in emerging economies, a rapidly aging population, the rise in point-of-care testing, and the rising importance of personalized medicine. However, factors such as stringent regulatory frameworks and a shortage of budget and labor are restraining the growth of the market.

In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market, followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of in vitro disgnostic tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.

The key players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Becton, Dickson and Company (U.S.), Siemens Healthcare (Germany), Diagnostica Stago SAS (France), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), ARKRAY, Inc. (Japan), Bio-Rad Laboratories, Inc. (U.S.), DiaSorin S.p.A. (Italy), Sysmex Corporation (Japan), bioMérieux (France), HORIBA, Ltd. (Japan), and Alere, Inc. (U.S.).

- Abbott Laboratories, Inc
- Alere, Inc
- Arkray, Inc
- Bayer AG
- Becton, Dickinson And Company
- Bio-Rad Laboratories, Inc
- Biomerieux
- Danaher Corporation
- Diagnostica Stago Sas
- Diasorin SPA
- Hologic, Inc
- Horiba, Ltd
- Johnson & Johnson
- Novartis International Ag
- Qiagen NV
- Roche Diagnostics Limited
- Siemens Healthcare
- Sysmex Corporation
- Thermo Fisher Scientific, Inc

Question Does this report include figures or tables on total revenue by end-user segmentation related to Chapter 7?
Answer Chapter 7 does include figures and a table on total revenue by end-user segmentation.
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos